Matteo Bassetti to Bacteremia
This is a "connection" page, showing publications Matteo Bassetti has written about Bacteremia.
Connection Strength
2.575
-
Bloodstream infections in critically ill patients with COVID-19. Eur J Clin Invest. 2020 Oct; 50(10):e13319.
Score: 0.387
-
Role of procalcitonin in bacteremic patients and its potential use in predicting infection etiology. Expert Rev Anti Infect Ther. 2019 02; 17(2):99-105.
Score: 0.346
-
Comparison between procalcitonin and C-reactive protein to predict blood culture results in ICU patients. Crit Care. 2018 10 05; 22(1):252.
Score: 0.340
-
A prognostic score for the resolution of bacteremia by Gram-negative bacteria resistant to carbapenems. Eur J Clin Microbiol Infect Dis. 2018 Nov; 37(11):2083-2089.
Score: 0.336
-
Predictors of Mortality with Staphylococcus aureus Bacteremia in Elderly Adults. J Am Geriatr Soc. 2018 07; 66(7):1284-1289.
Score: 0.329
-
Characteristics of Staphylococcus aureus Bacteraemia and Predictors of Early and Late Mortality. PLoS One. 2017; 12(2):e0170236.
Score: 0.303
-
Bloodstream infections caused by carbapenem-resistant Acinetobacter baumannii: Clinical features, therapy and outcome from a multicenter study. J Infect. 2019 08; 79(2):130-138.
Score: 0.089
-
Rational approach in the management of Pseudomonas aeruginosa infections. Curr Opin Infect Dis. 2018 12; 31(6):578-586.
Score: 0.086
-
Ceftolozane/tazobactam for the treatment of serious Pseudomonas aeruginosa infections: a multicentre nationwide clinical experience. Int J Antimicrob Agents. 2019 Apr; 53(4):408-415.
Score: 0.086
-
Effect of Piperacillin-Tazobactam vs Meropenem on 30-Day Mortality for Patients With E coli or Klebsiella pneumoniae Bloodstream Infection and Ceftriaxone Resistance: A Randomized Clinical Trial. JAMA. 2018 09 11; 320(10):984-994.
Score: 0.085
-
Population Pharmacokinetics of High-Dose Continuous-Infusion Meropenem and Considerations for Use in the Treatment of Infections Due to KPC-Producing Klebsiella pneumoniae. Antimicrob Agents Chemother. 2017 10; 61(10).
Score: 0.079
-
Effect of combination therapy containing a high-dose carbapenem on mortality in patients with carbapenem-resistant Klebsiella pneumoniae bloodstream infection. Int J Antimicrob Agents. 2018 Feb; 51(2):244-248.
Score: 0.079
-
Italian nationwide survey on Pseudomonas aeruginosa from invasive infections: activity of ceftolozane/tazobactam and comparators, and molecular epidemiology of carbapenemase producers. J Antimicrob Chemother. 2018 03 01; 73(3):664-671.
Score: 0.020
-
Hospital-acquired infections and leading pathogens detected in a regional university adult acute-care hospital in Genoa, Liguria, Italy: results from a prevalence study. J Prev Med Hyg. 2010 Jun; 51(2):80-6.
Score: 0.012